1. Our Ethical Foundation
The Express Highs Blog operates in a space where ethics are not optional — they are essential. We publish content about legal highs, research chemicals, cannabinoids, CBD, cannabis, and psychedelics. These are subjects that touch on personal freedom, public health, harm reduction, regulatory compliance, and scientific integrity all at once. Our readers trust us to guide them through a complex and fast-moving landscape with honesty, responsibility, and respect.
This Ethics Policy sets out the principles that govern everything we publish, how we treat our readers, how we manage commercial relationships, and how we hold ourselves accountable when we fall short.
2. Editorial Independence
The Express Highs Blog is commercially connected to the Express Highs retail store. We are transparent about that relationship in our Ownership & Funding Disclosure. However, commercial connection does not mean commercial control over editorial content.
Our editorial team operates under the following commitments:
No paid editorial placement. No external brand, supplier, or manufacturer can pay to have their product reviewed favourably, featured in a guide, or recommended to our readers. Editorial decisions are made on the basis of accuracy, relevance, and reader value — not commercial arrangement.
No suppression of negative information. If a product we sell carries significant risks, those risks are reported honestly in our content. If a substance has a poor safety profile relative to alternatives, we say so. Our readers’ safety takes precedence over our sales figures.
No interference from commercial partners. Suppliers, distributors, and manufacturers whose products appear on expresshighs.com have no editorial input into blog content. They may not request changes to published articles, request removal of critical information, or pre-approve content before publication.
Internal promotions are clearly contextualised. When we publish content that is inherently promotional — such as a product return announcement or a new stock alert — readers should understand that this content originates from us, about our own products. We do not dress commercial announcements as independent editorial.
3. Honesty and Accuracy
We commit to publishing only what we genuinely believe to be true and accurate at the time of publication. Specifically:
We do not exaggerate effects. Describing a substance’s effects in inflated or sensationalised terms to drive sales is something we actively avoid. Product guides and explainers are written to reflect what current evidence and user experience actually suggest, not what would make a product sound most appealing.
We cite our sources. Claims about pharmacology, safety, dosage, or legal status are supported by references to primary sources wherever possible — peer-reviewed literature, official regulatory bodies, manufacturer documentation, or established harm-reduction organisations.
We distinguish fact from opinion. Where content reflects the view of a writer or the position of Express Highs rather than established fact, this is made clear. Opinion and analysis are not presented as settled science.
We acknowledge uncertainty. Research on novel cannabinoids, research chemicals, and psychedelic compounds is often limited or preliminary. Where the evidence base is thin or contested, we say so explicitly rather than overstating confidence in the available data.
We correct our mistakes. When we publish something inaccurate, we correct it promptly and transparently in accordance with our Corrections Policy. We do not quietly edit articles to remove errors without disclosure.
4. Harm Reduction as an Editorial Priority
Express Highs takes harm reduction seriously. We believe that adults have the right to make informed choices about legal substances, and that providing clear, accurate, and non-judgmental safety information is one of the most important things this blog can do.
Our harm reduction commitments include:
Dosage guidance is treated as safety-critical content. Articles covering dosage — whether for HHC isolates, psychedelic truffles, LSD analogues, or any other substance — are held to the highest accuracy standard on this blog. Dosage errors are treated as urgent corrections. We never round figures for convenience or present ranges more confidently than the evidence supports.
Risks are reported alongside effects. We do not publish articles that describe the desirable effects of a substance without also addressing its known risks, contraindications, and safety considerations. Positive effects and potential harms are presented together, not in separate articles designed to make products look more appealing.
We do not target vulnerable audiences. Our content is intended for informed adults. We do not produce content designed to appeal to minors, to encourage first-time use by inexperienced individuals without appropriate context, or to minimise the risks of substances for audiences who may be particularly susceptible to harm.
We do not encourage illegal use. All content on this blog is produced with the understanding that the legality of any given substance varies by jurisdiction. We consistently remind readers to verify the legal status of any substance in their own country before purchase or use. We do not publish content designed to help readers circumvent the law.
5. Legal Compliance and Responsible Publishing
Express Highs operates across multiple European and international markets, each with its own regulatory framework governing cannabinoids, research chemicals, psychedelics, and related substances. Our ethical obligations extend to how we handle legal complexity in our content.
We keep legal information current. Laws in this space change frequently and sometimes rapidly. We treat outdated legal status information as a content error and prioritise updating it. We do not allow articles describing a substance as legal to remain live without review when we become aware that the legal status has changed.
We do not provide legal advice. Information about the legal status of substances published on this blog is provided for general informational purposes only. It does not constitute legal advice, and readers are responsible for verifying applicable laws in their own jurisdiction.
We do not facilitate access to controlled substances. Where a substance is a controlled drug in a given jurisdiction, our content does not provide guidance on how to acquire, import, or use it in defiance of local law. Our editorial focus is on products that are legal in the markets we serve.
We comply with advertising standards. Any promotional content produced in connection with the Express Highs brand — whether on this blog or elsewhere — adheres to applicable advertising regulations, including those governing health claims, age restrictions, and the promotion of psychoactive substances.
6. Conflicts of Interest
Given the commercial relationship between this blog and the Express Highs retail store, conflicts of interest are an inherent and acknowledged feature of our operation. We manage them as follows:
We disclose the conflict. Our Ownership & Funding Disclosure makes clear that this blog is owned and funded by the same company that sells the products it discusses. Readers are never left in any doubt about this relationship.
We apply the same editorial standards to our own products as to others. A product sold by Express Highs is held to the same accuracy and honesty standards in our editorial content as any other product or substance we write about.
Writers declare personal interests. Any writer or contributor who has a personal financial stake in a product, brand, or company being discussed in their article must declare this before publication. Content with undisclosed personal conflicts of interest is not published.
We do not review products we cannot assess honestly. If our commercial relationship with a supplier or product category prevents us from providing an honest assessment, we do not publish a review. We would rather not cover something than cover it dishonestly.
7. Respect for Our Readers
Our readers come to Express Highs for information they can rely on. We treat that trust as a responsibility.
We do not manufacture urgency. Sales-driven language designed to pressure readers into purchases — artificial scarcity claims, exaggerated limited-time framing, or fear-based messaging — has no place in our editorial content.
We respect reader privacy. Data collected from readers through newsletter subscriptions, comment submissions, or contact forms is handled in accordance with our Privacy Policy and applicable data protection law. We do not sell reader data to third parties.
We welcome dissenting views. Readers who disagree with our content, challenge our conclusions, or submit corrections are treated with respect. We do not remove critical comments or feedback submitted in good faith.
We do not discriminate. Our content is produced without bias on the grounds of nationality, gender, age, sexual orientation, religion, or any other protected characteristic. Our editorial voice is inclusive and respectful of the diverse international readership we serve.
8. Standards for Contributors and Writers
All writers and contributors producing content for the Express Highs Blog are expected to adhere to this Ethics Policy in full. Specifically, contributors must:
- Write only on subjects within their knowledge or where they have conducted adequate research
- Disclose any personal, financial, or professional conflicts of interest relating to their subject matter
- Not fabricate quotes, data, study results, or sources
- Not plagiarise content from other publications
- Not accept payment, gifts, or benefits from third parties in exchange for favourable coverage
- Notify the editorial team promptly if they become aware of an error in their published work
Breaches of these standards by contributors are taken seriously and may result in correction, retraction, and termination of the contributor relationship.
9. Use of Artificial Intelligence
Where AI tools are used to assist in the research, drafting, or editing of blog content, this does not reduce the editorial responsibility of the human writer or editor overseeing that content. All AI-assisted content is reviewed, verified, and approved by a human member of the Express Highs editorial team before publication. AI tools are not used as a substitute for expert knowledge or original source verification, particularly in safety-critical content areas such as dosage, pharmacology, and legal status.
10. Accountability
We hold ourselves accountable to the standards set out in this policy through the following mechanisms:
Reader feedback — Any reader who believes this Ethics Policy has been breached is encouraged to contact us. We investigate all such reports in good faith.
Editorial review — This policy is reviewed by the Express Highs editorial team every six months and updated where our practices or the publishing environment require it.
Corrections and transparency — Our Corrections Policy and Corrections Log provide an ongoing public record of where our content has fallen short of our accuracy standards and how we addressed it.
No retaliation — Readers, contributors, or staff who raise ethical concerns about our content or practices in good faith are protected from retaliation of any kind.
11. Reporting an Ethics Concern
If you believe content published on this blog violates this Ethics Policy, please contact our editorial team:
Contact form Subject line: “Ethics Concern – [Article Title or Topic]”
For urgent concerns relating to safety-critical content:
Subject line: “URGENT ETHICS – [Article Title]”
All reports are treated confidentially and reviewed within seven business days. Urgent safety-related reports are reviewed within 24 hours.
12. Policy Review
This Ethics Policy is reviewed every six months or following any material change to our editorial structure, ownership, funding, or publishing practices. The current version is always available at:
Express Highs — Elevated information. Grounded in ethics.

